Study open

Ventura-1 study for depression

Depression is a mental illness characterized by the gloomy mood and listlessness of life. This often with a loss of interest or pleasure. In addition, there are other symptoms that may arise with finally recurring thoughts of death as an example. The core symptoms manifest throughout most of the day.
Have you been diagnosed with depression? Are you already taking antidepressants and feel you are still experiencing the depressive symptoms?


The Ventura-1 study is studying a new drug and what it may contribute in the treatment against improving depression. It will be tested in combination with your current antidepressant. The study will consist of 3 periods involving a screening period, a treatment period and a follow-up. Later, you will have the option to participate in a follow-up period of the study.


At Anima, each examination is preceded by a screening interview where you will have the opportunity to discuss with the doctor any further questions or uncertainties in a discreet manner.

Study participation
50% will receive a placebo
50% will receive the active study medication

Sign up

Target

  • You are between 18 and 74 years old
  • Depression has already been diagnosed
  • You are already taking an anti-depressant

Program

  • The study lasts about 3 months (with possible continuation in Ventura 3)
  • You will need to come to the study center at least 7 times during this period.
  • There will be 3 phone appointments (follow-ups) during this period.
  • In the possible follow-up study, you will be administered only the experimental product for 52 weeks, even if you previously took placebo.

Location

Anima Research Center
Alkerstraat 32Z (Block D)
3570 Alken
Belgium

Reimbursement

You will receive an allowance to compensate for the distance traveled. This compensation is a fixed amount of €25.00 under 100km, €50.00 over 100km per visit to the study center.